Ze-Fei Jiang

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial

Xi-Chun Hu, Jian Zhang, Bing-He Xu et al. · The Lancet Oncology · 2015 · 279 citations

First-line Therapy, Breast Oncology, Oncology +7

Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro

Jianming Xu, San‐tai Song, Zhong‐ming Tang et al. · Breast Cancer Research and Treatment · 1999 · 53 citations

Predictive Chemotherapy, Advanced Breast Cancer, Breast Oncology +10

A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer

Ke‐Da Yu, Ying Zhou, Guang‐Yu Liu et al. · Breast Cancer Research and Treatment · 2012 · 49 citations

Nursing, Breast Oncology, Medicine +13

Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients

Bing-He Xu, Ze-Fei Jiang, Daniel T. T. Chua et al. · Chinese Journal of Cancer · 2011 · 43 citations · Full text

Pegylated filgrastim is comparable with filgrastim as support for commonly used chemotherapy regimens

Yuan-Kai Shi, Qiang Chen, Yun-Zhong Zhu et al. · Anti-Cancer Drugs · 2013 · 27 citations

Pharmacotherapy, Safety Parameters, Metronomic Chemotherapy +20